Based on our knowledge, the present study is the first to compare the significance of these proteins in relation to the well-established tumor markers (CEA and CA19-9) and the marker of inflammation—C-reactive protein (CRP)— in the diagnosis and progression of GC. The gene discussed is CRP; the disease is gastric cancer.